Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00585195
Title A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer (PROFILE 1001)
Acronym PROFILE 1001
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Additional content available in CKB BOOST